Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
US Army
McKesson
Argus Health
Daiichi Sankyo

Generated: July 22, 2019

DrugPatentWatch Database Preview

BUPIVACAINE HYDROCHLORIDE Drug Profile

Try a free trialSee Plans and Pricing

« Back to Dashboard

When do Bupivacaine Hydrochloride patents expire, and when can generic versions of Bupivacaine Hydrochloride launch?

Bupivacaine Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, Hospira, Mylan Asi, Novocol Healthcare, B Braun Medical Inc, Baxter Hlthcare Corp, Septodont, and Intl Medicated. and is included in twenty-eight NDAs.

The generic ingredient in BUPIVACAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.

Drug patent expirations by year for BUPIVACAINE HYDROCHLORIDE
Pharmacology for BUPIVACAINE HYDROCHLORIDE
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Synonyms for BUPIVACAINE HYDROCHLORIDE
(+-)-1-Butyl-2',6'-pipecoloxylidide monohydrochloride, monohydrate
(+-)-Bupivacaine hydrochloride
1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium chloride
1-butyl-2-piperidylformo-2',6'-xylidide hydrochloride
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride dl-1-n-Butylpiperidine-2-carboxylic acid 2,6-dimethylanilide hydrochloride
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide monohydrochloride
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride
1-Butyl-N-[2,6-dimethylphenyl]-2-piperidinecarboxamide
14252-80-3
14252-80-3 (HCl)
15233-43-9
18010-40-7
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochlorde, monohydrate
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, monohydrate
2-Piperidinecarboxamide,6-dimethylphenyl)-, hydrochloride
2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride
2',6'-Pipecoloxylidide, 1-butyl-, monohydrochloride
52B803
73360-54-0 (HCl.H2O)
AB2000569
AC1L21TT
ACT04725
AH 2250
AH-2250
AK481431
AKOS015889322
AN-14283
AN-18756
AOB6341
API0001784
AX8018312
B3925
BCP22697
BCP22708
BCP9000461
Bicain
Bupicacain hydrochlorid-1-wasser
bupivacain hydrochloride
Bupivacaine (hydrochloride)
Bupivacaine HCL
bupivacaine hydrochloride (anhydrous)
Bupivacaine hydrochloride (Marcain)
Bupivacaine hydrochloride [JAN]
Bupivacaine hydrochloride [USAN]
Bupivacaine hydrochloride anhydrous
Bupivacaine hydrochloride kit
Bupivacaine hydrochloride preservation free
bupivacaine monohydrochloride
CCG-39367
CHEBI:31322
CHEBI:77441
CHEMBL1200396
CS-2505
CTK8F8361
DTXSID0030877
EINECS 241-917-8
FD-0235
FT-0082605
FT-0607564
FT-0623287
H875
HMS1568N12
HMS1922I12
HY-B0405A
I01-1868
J-011502
K-4565
KB-48484
KS-00000M4Q
KS-00000XIC
LAC 43
LAC-43
levobupivacaine hydrochloride (anhydrous)
LS-185059
LS-2113
Marcain
Marcain;Marcaine;Sensorcaine;Vivacaine
Marcaine hydrochloride preservation free
Marcaine Spinal
MCULE-5414144502
MLS001361336
MLS002154259
MNarcaine hydrochloride
MolPort-003-666-503
N-(2,6-dimethylphenyl)(1-butyl(2-piperidyl))carboxamide, chloride
NCGC00095072-01
NCGC00095072-02
NSC-119660
NSC-758631
NSC119660
NSC758631
Pharmakon1600-01503818
Prestwick_894
Q-100158
rac-1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium chloride
rac-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride
s2454
SC-24334
SC-94629
SCHEMBL34374
Sensorcaine
SIEYLFHKZGLBNX-UHFFFAOYSA-N
SKY 0302
SMR000058218
SPECTRUM1503818
SR-05000001874
SR-05000001874-3
ST013772
SW197015-3
Vivacaine
Win 11,318
Win 11318 HCl
WIN-11318

US Patents and Regulatory Information for BUPIVACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 203895-002 Nov 5, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira BUPIVACAINE HYDROCHLORIDE KIT bupivacaine hydrochloride INJECTABLE;INJECTION 019978-001 Sep 3, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 203895-003 Nov 5, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chinese Patent Office
Merck
Johnson and Johnson
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.